<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03452917</url>
  </required_header>
  <id_info>
    <org_study_id>51605</org_study_id>
    <secondary_id>R01HL129722</secondary_id>
    <nct_id>NCT03452917</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest</brief_title>
  <acronym>SNOCAT</acronym>
  <official_title>Randomized Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in&#xD;
      Seattle/King County will be enrolled. This will be a randomized clinical trial and patients&#xD;
      will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo&#xD;
      during resuscitation in the field by paramedics. The primary outcome will be proportion of&#xD;
      patients surviving to hospital admission.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hemodynamic effects of the optimal dose of IV nitrite administered in patients with&#xD;
      cardiac arrest are unknown. A significant negative hemodynamic effect from nitrite would&#xD;
      decrease the proportion of patients admitted to the hospital, increase rate of re-arrest, or&#xD;
      increase the need for vasopressor support in the field. In Seattle/King County, typically 40%&#xD;
      of out-of-hospital cardiac arrest patients attended to by paramedics have Return of&#xD;
      spontaneous circulation (ROSC) and are admitted to the hospital. In this study, 1500 patients&#xD;
      with out-of-hospital cardiac arrest who are undergoing resuscitation by paramedics will be&#xD;
      randomized to receive placebo (n=500) or 45 mg IV (n=500) or 60 mg dose (n=500) of sodium&#xD;
      nitrite. The study will have 80% power to detect an absolute increase in hospital admission&#xD;
      rate of 8% (1-sided .05 level test for each of the two comparisons (45 mg vs placebo and 60&#xD;
      mg vs placebo, no adjustment for multiple comparisons), with a hospital admission rate of 40%&#xD;
      in the placebo group and with one interim analysis and stopping only for potential futility&#xD;
      and/or harm). The investigators will examine the proportion of patients who survive to&#xD;
      discharge as a secondary measure of efficacy.&#xD;
&#xD;
      Patients will be eligible for this study if:&#xD;
&#xD;
        1. Intravenous access (IV)/intraosseous access(IO)&#xD;
&#xD;
        2. Cardiac arrest, either Ventricular Fibrillation (VF) or non-VF patients receiving&#xD;
           Advanced Cardiac Life Support (ACLS) by Seattle/King County paramedics.&#xD;
&#xD;
        3. Age 18 years or older&#xD;
&#xD;
        4. Comatose&#xD;
&#xD;
      Exclusion Criteria&#xD;
&#xD;
        1. Traumatic cause of cardiac arrest&#xD;
&#xD;
        2. Prisoner, pregnancy, age less than 18 (special population/vulnerable population)&#xD;
&#xD;
        3. Known DNAR&#xD;
&#xD;
        4. Drowning as cause of arrest.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 8, 2018</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival to hospital admission</measure>
    <time_frame>within 24 hours after out of hospital cardiac arrest</time_frame>
    <description>Patient has sustained pulse at arrival to the emergency department</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival to discharge</measure>
    <time_frame>within 3-6 months after cardiac arrest</time_frame>
    <description>Patient alive at time of discharge from hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days in ICU</measure>
    <time_frame>Within first 3 months of hospital admission</time_frame>
    <description>Number of days the patient is admitted to the Intensive Care Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>survival to 24 hours</measure>
    <time_frame>within first 24 h after hospital admission</time_frame>
    <description>Patient is alive after the first 24 hours after admission to the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-arrest or use of pressers in field by paramedics</measure>
    <time_frame>before hospital arrival</time_frame>
    <description>Patient loses pulses and or required use of pressers in the field</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival to 48 hours after admission to hospital</measure>
    <time_frame>within first 48 hours after admission to hospital</time_frame>
    <description>Patient is alive after first 48 hours after admission to the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival to 72 hours after admission to hospital</measure>
    <time_frame>within first 72 hours after admission to hospital</time_frame>
    <description>Patient is alive after first 72 hours after admission to the hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1502</enrollment>
  <condition>Out-Of-Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 ml of normal saline (n=500)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sodium nitrite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>45 mg IV of sodium nitrite (n=500) or 60 mg IV sodium nitrite (n=500) given during active resuscitation from out of hospital cardiac arrest.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>500 patients will 2 ml of normal saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium nitrite 45 mg</intervention_name>
    <description>500 patients will receive 45 mg IV sodium nitrite</description>
    <arm_group_label>sodium nitrite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium nitrite 60 mg</intervention_name>
    <description>500 patients will receive a dose of 60 mg IV sodium nitrite</description>
    <arm_group_label>sodium nitrite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cardiac arrest, either VF or non-VF, patients receiving ACLS by paramedics&#xD;
&#xD;
          -  IV or IO access&#xD;
&#xD;
          -  Comatose&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  traumatic cause of cardiac arrest&#xD;
&#xD;
          -  prisoner, pregnancy&#xD;
&#xD;
          -  known DNAR&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Francis Kim</investigator_full_name>
    <investigator_title>Professor, Medicine/Division of Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>January 3, 2021</submitted>
    <returned>January 21, 2021</returned>
    <submitted>April 27, 2021</submitted>
    <returned>May 19, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

